The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global High Content Screening Market Research Report 2024

Global High Content Screening Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1713690

No of Pages : 86

Ask Your Query

Synopsis

High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluorescence imaging, and other visualization processes to get quantitative data from cell populations.

Global High Content Screening market is projected to reach US$ 993.8 million in 2029, increasing from US$ 563.6 million in 2022, with the CAGR of 8.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole High Content Screening market research.

The high-content screening market is anticipated to witness significant growth during the forecast period, owing to the ability of HCS to study several parameters in a complex biological system simultaneously.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global High Content Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Molecular Devices
  •     Thermo Fisher Scientific
  •     PerkinElmer Inc.
  •     Becton
  •     GE Healthcare
  •     Dickinson and Company
  •     Merck KGaA
  •     Cell Signaling Technology
  •     Thorlabs, Inc.
  •     Genedata AG
  •     Yokogawa Electric Corporation

Segment by Type

  •     Consumables
  •     Microplates
  •     Instruments
  •     Software and Service

Segment by Application

  •     Primary & Secondary Screening
  •     Compound Profiling
  •     Target Identification & Validation

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The High Content Screening report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 

 

Index

 

   1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global High Content Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Consumables
        1.2.3 Microplates
        1.2.4 Instruments
        1.2.5 Software and Service
    1.3 Market by Application
        1.3.1 Global High Content Screening Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Primary & Secondary Screening
        1.3.3 Compound Profiling
        1.3.4 Target Identification & Validation
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global High Content Screening Market Perspective (2018-2029)
    2.2 High Content Screening Growth Trends by Region
        2.2.1 Global High Content Screening Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 High Content Screening Historic Market Size by Region (2018-2023)
        2.2.3 High Content Screening Forecasted Market Size by Region (2024-2029)
    2.3 High Content Screening Market Dynamics
        2.3.1 High Content Screening Industry Trends
        2.3.2 High Content Screening Market Drivers
        2.3.3 High Content Screening Market Challenges
        2.3.4 High Content Screening Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top High Content Screening Players by Revenue
        3.1.1 Global Top High Content Screening Players by Revenue (2018-2023)
        3.1.2 Global High Content Screening Revenue Market Share by Players (2018-2023)
    3.2 Global High Content Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by High Content Screening Revenue
    3.4 Global High Content Screening Market Concentration Ratio
        3.4.1 Global High Content Screening Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by High Content Screening Revenue in 2022
    3.5 High Content Screening Key Players Head office and Area Served
    3.6 Key Players High Content Screening Product Solution and Service
    3.7 Date of Enter into High Content Screening Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 High Content Screening Breakdown Data by Type
    4.1 Global High Content Screening Historic Market Size by Type (2018-2023)
    4.2 Global High Content Screening Forecasted Market Size by Type (2024-2029)

 5 High Content Screening Breakdown Data by Application
    5.1 Global High Content Screening Historic Market Size by Application (2018-2023)
    5.2 Global High Content Screening Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America High Content Screening Market Size (2018-2029)
    6.2 North America High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America High Content Screening Market Size by Country (2018-2023)
    6.4 North America High Content Screening Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe High Content Screening Market Size (2018-2029)
    7.2 Europe High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe High Content Screening Market Size by Country (2018-2023)
    7.4 Europe High Content Screening Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific High Content Screening Market Size (2018-2029)
    8.2 Asia-Pacific High Content Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific High Content Screening Market Size by Region (2018-2023)
    8.4 Asia-Pacific High Content Screening Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America High Content Screening Market Size (2018-2029)
    9.2 Latin America High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America High Content Screening Market Size by Country (2018-2023)
    9.4 Latin America High Content Screening Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa High Content Screening Market Size (2018-2029)
    10.2 Middle East & Africa High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa High Content Screening Market Size by Country (2018-2023)
    10.4 Middle East & Africa High Content Screening Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Molecular Devices
        11.1.1 Molecular Devices Company Detail
        11.1.2 Molecular Devices Business Overview
        11.1.3 Molecular Devices High Content Screening Introduction
        11.1.4 Molecular Devices Revenue in High Content Screening Business (2018-2023)
        11.1.5 Molecular Devices Recent Development
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Detail
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific High Content Screening Introduction
        11.2.4 Thermo Fisher Scientific Revenue in High Content Screening Business (2018-2023)
        11.2.5 Thermo Fisher Scientific Recent Development
    11.3 PerkinElmer Inc.
        11.3.1 PerkinElmer Inc. Company Detail
        11.3.2 PerkinElmer Inc. Business Overview
        11.3.3 PerkinElmer Inc. High Content Screening Introduction
        11.3.4 PerkinElmer Inc. Revenue in High Content Screening Business (2018-2023)
        11.3.5 PerkinElmer Inc. Recent Development
    11.4 Becton
        11.4.1 Becton Company Detail
        11.4.2 Becton Business Overview
        11.4.3 Becton High Content Screening Introduction
        11.4.4 Becton Revenue in High Content Screening Business (2018-2023)
        11.4.5 Becton Recent Development
    11.5 GE Healthcare
        11.5.1 GE Healthcare Company Detail
        11.5.2 GE Healthcare Business Overview
        11.5.3 GE Healthcare High Content Screening Introduction
        11.5.4 GE Healthcare Revenue in High Content Screening Business (2018-2023)
        11.5.5 GE Healthcare Recent Development
    11.6 Dickinson and Company
        11.6.1 Dickinson and Company Company Detail
        11.6.2 Dickinson and Company Business Overview
        11.6.3 Dickinson and Company High Content Screening Introduction
        11.6.4 Dickinson and Company Revenue in High Content Screening Business (2018-2023)
        11.6.5 Dickinson and Company Recent Development
    11.7 Merck KGaA
        11.7.1 Merck KGaA Company Detail
        11.7.2 Merck KGaA Business Overview
        11.7.3 Merck KGaA High Content Screening Introduction
        11.7.4 Merck KGaA Revenue in High Content Screening Business (2018-2023)
        11.7.5 Merck KGaA Recent Development
    11.8 Cell Signaling Technology
        11.8.1 Cell Signaling Technology Company Detail
        11.8.2 Cell Signaling Technology Business Overview
        11.8.3 Cell Signaling Technology High Content Screening Introduction
        11.8.4 Cell Signaling Technology Revenue in High Content Screening Business (2018-2023)
        11.8.5 Cell Signaling Technology Recent Development
    11.9 Thorlabs, Inc.
        11.9.1 Thorlabs, Inc. Company Detail
        11.9.2 Thorlabs, Inc. Business Overview
        11.9.3 Thorlabs, Inc. High Content Screening Introduction
        11.9.4 Thorlabs, Inc. Revenue in High Content Screening Business (2018-2023)
        11.9.5 Thorlabs, Inc. Recent Development
    11.10 Genedata AG
        11.10.1 Genedata AG Company Detail
        11.10.2 Genedata AG Business Overview
        11.10.3 Genedata AG High Content Screening Introduction
        11.10.4 Genedata AG Revenue in High Content Screening Business (2018-2023)
        11.10.5 Genedata AG Recent Development
    11.11 Yokogawa Electric Corporation
        11.11.1 Yokogawa Electric Corporation Company Detail
        11.11.2 Yokogawa Electric Corporation Business Overview
        11.11.3 Yokogawa Electric Corporation High Content Screening Introduction
        11.11.4 Yokogawa Electric Corporation Revenue in High Content Screening Business (2018-2023)
        11.11.5 Yokogawa Electric Corporation Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock